Bibliography
- VIRAG R, FRYDEN D, BEGMAN M, VIRAG H: Intracav- injection of papaverine as a diagnostic and therapeutic method in erectile failure. Andrology (1984) 35:79. R: Intracavernous injection of papaverine for erectile failure. Lancet (1982) 2:938. report of intracavernosal papaverine initiating erection. HEYDENM B, DONATUCCI C, KAULA N, LUE T: Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. J. Urol. (1993) 149:1288–1290.
- WALDERHASER, M SCHRAMEK P: Effeciency and side effects of prstaglandin El in the treatment of erectile dysfunction. J. Urol. (1988) 140:525–527.
- EARLE C, KEOGH E, WISNIEWSKI Z et al: Prostaglandin El therapy for impotence, comparison with papaverine. j Urol (1990) 143:57–59.
- FLOTH A, SCHRAMEK P: Intracavernous injection of prostaglandin El in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin El alone. J. Urol. (1991) 145:50–59.
- WOLFSON B, PICKETT S, SCOTT N, DEKENION J, RAJFER J: Intraurethral prostaglandin E2 cream: A possible alternative treatment for ED. Urology (1993) 42:73.
- KIM E, MCVARY K: Topical prostaglandin-El for the treatment of erectile dysfuntion. J. Urol. (1995) 153:1828–1830.
- PADAM-NATHAN H et al.: Treatment of men with dysfunction with tranurethral alprostadil. New Engl. J. Med. (1997) 336:1.
- •First detailed review of clinical trials of transurethral alprostadil.
- CAVERJECT PACKAGE INSERT: Upjohn, Kalamazoo, Mi.
- EDEX PACKAGE INSERT
- MUSE package insert, Vivus, Mountain View, Ca.
- LUE T, TANAGHO E: Function anatomy and mechanism of penile erection: contemporary management of impotence and infertility. Williams & Wilkens, Baltimore, MD, USA (1988).
- VAN AHLEN H, PESKAR B, STICHT G, HERTFELDER H: Pharmacokinetics of vasoactive substances adminis-tered into the human corpus cavernosum. J. Urol. (1994) 151:1227–1230.
- •Detailed description of pharmacokinetics of intracavernosal agents.
- GODSCHALK M, CHEN J, KATZ P, MULLIGAN T: Treatment of erectile failure with prostaglandin El: a double-blind, placebo-controlled, dose response study../. Urol. (1994):1530.
- LINET 0, THE ALPROSTADILE STUDY GROUP: Efficacy safety of intracavernosal alprostadil in men with erectile dysfunction. New Engl. J. Med. (1996) 334:873.
- •First detailed report of clinical trials of intracavernosal alprostadil.
- FULGHAM P, COCHRAN J, DENMAN J et al.: Disappointing results with transurethral alprostadil men with erectile dysfunction (ED) in a urology practice setting. J. Urol (1998) 159(5):237.
- MULLHALL J, PARKER M: Evaluation of the consistency of response to intra-urethral prostaglandin (MUSE®) during at-home use. J. Urol (1998) 159(5):237.
- COSTABILE R: Efficacy of transurethral alprostadil, (MUSE®) vs. transurethral alprostadil/prazosin (ALIBRA') in men with complete, organic erectile dysfunction. J. Urol (1998) 159(5):237.
- PETERSON C, BENNETT A, HELLSTROM W et al.: Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations. J. Urol. (1998) 159:1523–1528.
- COSTABILE R: Efficacy of transurethral alprostadil, (MUSE®) vs. transurethral alprostadil/prazosin (ALIBRA') in men with complete, organic erectile dysfunction. J. Urol (1998) 159(5):237.
- LEWIS R: Combined use of transurethral alprostadil and an adjustable penile constriction band in men with erectile dysfunction: results from a multicenter trial. J. Urol. (1998) 159(5): 237.
- PADMA-NATHAN H, TAM P PLACE V: Improved erectile dysfunction response to transurethral alprostadil by use of a novel, adjustable penile band. J. Urol. (1997) 157(4):181.
- TAMP, KELLER T, POPPITI R et al: Hemodynamic effects of transurethral alprostadil measured by color duplex ultrasonography in men with erectile dysfunction. J. Urol. (1998) 160:1321-1324. A Costabile Services University, Walter Reed Army Medical Center, Washington DC, USA